IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS

Shahar Shelly, John R. Mills, Jennifer M. Martinez-Thompson, Matt M. Rofforth, Sean J. Pittock, Jay Mandrekar, James Douglas Triplett, Michelle Mauermann, Divyanshu Dubey, Dr J. Klein

Research output: Contribution to journalLetter

Original languageEnglish (US)
Article number321977
JournalJournal of Neurology, Neurosurgery and Psychiatry
DOIs
StateAccepted/In press - Jan 1 2019

Keywords

  • CIDP
  • gangliosides
  • MADSAM
  • MGUS
  • MMN

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Shelly, S., Mills, J. R., Martinez-Thompson, J. M., Rofforth, M. M., Pittock, S. J., Mandrekar, J., Triplett, J. D., Mauermann, M., Dubey, D., & Klein, D. J. (Accepted/In press). IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS. Journal of Neurology, Neurosurgery and Psychiatry, [321977]. https://doi.org/10.1136/jnnp-2019-321977